Search | IOVS | ARVO Journals

Showing 1 – 20 of 27

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Articles December 2020

Assessing Residual Cone Function in Retinitis Pigmentosa Patients

PDF

Tasneem A. Arsiwalla; Elisa E. Cornish; Phuc Vuong Nguyen; Maria Korsakova; Haipha Ali; Nonna Saakova; Clare L. Fraser; Robyn V. Jamieson; John R. Grigg

Trans. Vis. Sci. Tech.. 2020; 9(13):29. doi: https://doi.org/10.1167/tvst.9.13.29

ARVO Annual Meeting Abstract June 2020

Who is getting clinically significant haze after Corneal Crossolinking for Keratoconus? A Save Sight Keratoconus Registry study

Stephanie Watson; Himal Kandel; Alex Ferdi; Vuong Nguyen; Aanchal Gupta; Marco Abbondanza; Laurence Sullivan; Andrew Apel; Richard A Mills; Jern Y Chen; Adam Watson; Constantinos Petsoglou; Nicholas Downie

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4067. doi:

ARVO Annual Meeting Abstract June 2020

Association between anatomical and clinical outcomes in patients treated with anti-vascular endothelial growth factor for neovascular age-related macular degeneration

Mark C Gillies; Vuong Nguyen; Calvo Pilar; Martin Puzo; Pierre-Henry GABRIELLE; Catherine P Creuzot Garcher; Florian Baudin; Benjamin Wolff; Louise O’ Toole; Laurent Castelnovo; Michel Guillaume; Daniel Barthelmes

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4214. doi:

ARVO Annual Meeting Abstract June 2020

Electrophysiological Assessment in Birdshot Chorioretinopathy: Use of a Portable Device in the Clinic

Anna Michelle Waldie; Angharad E Hobby; Isabelle Chow; Elisa Eleanor Cornish; Mathura Indusegaran; Alexandra Pekacka; Vuong Nguyen; Clare Fraser; Alison M Binns; Miles R. Stanford; Christopher Hammond; Peter J McCluskey; John R Grigg; Omar Mahroo

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):5045. doi:

ARVO Annual Meeting Abstract June 2020

Ranibizumab or Aflibercept for Diabetic Macular Edema: One-Year Comparison of Real-World Outcomes from Fight Retinal Blindness! Registry.

SANJEEB BHANDARI; Vuong Nguyen; Samantha Fraser-Bell; Hemal Mehta; Francesco Viola; Florian Baudin; Pierre-Henry Gabrielle; Catherine P Creuzot Garcher; Mark C Gillies; Daniel Barthelmes

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3289. doi:

ARVO Annual Meeting Abstract June 2020

5-year outcomes of corneal cross-linking: A Save Sight Keratoconus Registry study

Alex Ferdi; Vuong Nguyen; Himal Kandel; Jeremy Tan; Francisco Arnalich Montiel; Marco Abbondanza; Stephanie Watson

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2339. doi:

ARVO Annual Meeting Abstract June 2020

Comparison of Standard versus Accelerated corneal collagen cross-linking for keratoconus: one-year outcomes from Save Sight Keratoconus Registry study

Himal Kandel; Vuong Nguyen; Alex Ferdi; Aanchal Gupta; Marco Abbondanza; Laurence Sullivan; Andrew Apel; Richard A Mills; Jern Yee Chen; Adam Watson; Constantinos Petsoglou; Nicholas Downie; Stephanie Watson

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3570. doi:

ARVO Annual Meeting Abstract July 2019

Ten-Year Treatment Outcomes of Neovascular Age-Related Macular Degeneration

Mark C Gillies; SANJEEB BHANDARI; Benjamin Wolff; Jennifer Joan Arnold; Rohan W Essex; Stephanie Young; David M Squirrell; Daniel Barthelmes; Vuong Nguyen

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):111. doi:

ARVO Annual Meeting Abstract July 2019

Outcomes of suspending VEGF inhibitors for neovascular age-related macular degeneration when lesions have been inactive for 3 months

Vuong Nguyen; Anagha Vaze; Samanta Fraser-Bell; Jennifer Joan Arnold; Rohan W Essex; Daniel Barthelmes; Mark C Gillies

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):139. doi:

ARVO Annual Meeting Abstract July 2019

Assessing residual cone function in Retinitis Pigmentosa: electrophysiological and optical coherence tomography findings and correlation with visual acuity

Tasneem Arsiwalla; Elisa Eleanor Cornish; Vuong Nguyen; Robyn V Jamieson; John R Grigg

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4525. doi:

ARVO Annual Meeting Abstract July 2019

Changes in real world treatment patterns for diabetic macular edema and five year treatment outcomes: data from the Fight Retinal Blindness! Project

SANJEEB BHANDARI; Anne Catherine Biechl; Jennifer Joan Arnold; Stephanie Young; Samanta Fraser-Bell; Hemal Mehta; Mark C Gillies; Daniel Barthelmes; Vuong Nguyen

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2602. doi:

ARVO Annual Meeting Abstract July 2019

Twenty-four month outcomes of inflammatory choroidal neovascularization treated with intravitreal anti vascular endothelial growth factors: a comparison between two treatment regimens

Alessandro Invernizzi; Francesco Pichi; Richard Symes; Sophia Zagora; Vuong Nguyen; Stefano Erba; Alba Xhepa; Luca De Simone; Luca Cimino; Mark C Gillies; Peter J McCluskey

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3859. doi:

ARVO Annual Meeting Abstract July 2019

Real-world outcomes in patients with macular oedema secondary to central retinal vein occlusion receiving intravitreal anti-VEGF therapy in a UK public hospital setting

Sarah Ah-Moye; Pardis Zalmay; Magnus Theodorsson; Martin Lynn Harris; Riaz Asaria; Adrian Hunt; Daniel Barthelmes; Mark C Gillies; Vuong Nguyen; Hemal Mehta

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4061. doi:

ARVO Annual Meeting Abstract July 2019

Implementing the Save Sight Keratoconus Registry in the hospital setting

Alex Ferdi; Vuong Nguyen; Chameen Samarawickrama; Stephanie L Watson

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5455. doi:

ARVO Annual Meeting Abstract July 2018

Trainee-led vs. specialist-led management of neovascular age-related macular degeneration.

Rohan W. Essex; Vuong Nguyen; Vincent Daien; Sarah Steinmann; Richard Walton; Mark C Gillies; Daniel Barthelmes

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1463. doi:

ARVO Annual Meeting Abstract July 2018

The outcomes of corneal cross-linking for Keratoconus from routine clinical practice across 3 sites in Australia: Results from the Save Sight Keratoconus Registry

Alex Ferdi; Vuong Nguyen; Jeremy Tan; Yves Kerdraon; John Males; Nigel Morlet; Peter Beckinsale; Richard A Mills; Chris Go; Mark Daniell; Elsie Chan; Daniel Barthelmes; Amparo Herrera-Bond; Marco Garcia; Mark C Gillies; Stephanie L Watson

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4380. doi:

ARVO Annual Meeting Abstract July 2018

Five year outcomes of the Bevordex Study (a multicenter randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone).

Elisa Eleanor Cornish; Kelvin Yi Chong Teo; Mark C Gillies; Lyndell L Lim; Ian McAllister; Sutha Sanmugasundram; Vuong Nguyen; Sanjeewa Wickremasinghe; Hemal Mehta; Samantha Fraser-Bell

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4847. doi:

ARVO Annual Meeting Abstract July 2018

Real-world visual outcomes at 24 weeks in patients with diabetic macular edema receiving aflibercept intravitreal injections as per UK license.

Charles Hennings; Mira Deshmukh; Vuong Nguyen; Martin Harris; Riaz Asaria; Daniel Barthelmes; Mark C Gillies; Hemal Mehta

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3616. doi:

ARVO Annual Meeting Abstract July 2018

A Probabilistic Forecast of 12 Month Visual Outcomes of nAMD

Vuong Nguyen; Kelvin Teo; Judy Simpson; Vincent Daien; Daniel Barthelmes; Mark C Gillies; Richard Walton

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):829. doi:

ARVO Annual Meeting Abstract July 2018

Vision-related quality of life in keratoconus

JEREMY C.K. TAN; Vuong Nguyen; Alex Ferdi; Eva Fenwick; Stephanie L Watson

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5178. doi:

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Specify Date Range

Assessing Residual Cone Function in Retinitis Pigmentosa Patients

Who is getting clinically significant haze after Corneal Crossolinking for Keratoconus? A Save Sight Keratoconus Registry study

Association between anatomical and clinical outcomes in patients treated with anti-vascular endothelial growth factor for neovascular age-related macular degeneration

Electrophysiological Assessment in Birdshot Chorioretinopathy: Use of a Portable Device in the Clinic

Ranibizumab or Aflibercept for Diabetic Macular Edema: One-Year Comparison of Real-World Outcomes from Fight Retinal Blindness! Registry.

5-year outcomes of corneal cross-linking: A Save Sight Keratoconus Registry study

Comparison of Standard versus Accelerated corneal collagen cross-linking for keratoconus: one-year outcomes from Save Sight Keratoconus Registry study

Ten-Year Treatment Outcomes of Neovascular Age-Related Macular Degeneration

Outcomes of suspending VEGF inhibitors for neovascular age-related macular degeneration when lesions have been inactive for 3 months

Assessing residual cone function in Retinitis Pigmentosa: electrophysiological and optical coherence tomography findings and correlation with visual acuity

Changes in real world treatment patterns for diabetic macular edema and five year treatment outcomes: data from the Fight Retinal Blindness! Project

Twenty-four month outcomes of inflammatory choroidal neovascularization treated with intravitreal anti vascular endothelial growth factors: a comparison between two treatment regimens

Real-world outcomes in patients with macular oedema secondary to central retinal vein occlusion receiving intravitreal anti-VEGF therapy in a UK public hospital setting

Implementing the Save Sight Keratoconus Registry in the hospital setting

Trainee-led vs. specialist-led management of neovascular age-related macular degeneration.

The outcomes of corneal cross-linking for Keratoconus from routine clinical practice across 3 sites in Australia: Results from the Save Sight Keratoconus Registry

Five year outcomes of the Bevordex Study (a multicenter randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone).

Real-world visual outcomes at 24 weeks in patients with diabetic macular edema receiving aflibercept intravitreal injections as per UK license.

A Probabilistic Forecast of 12 Month Visual Outcomes of nAMD

Vision-related quality of life in keratoconus

To View More...

You must be signed into an individual account to use this feature.